日本药品价格管理启示  

Impression of Japanese experience to Chinese drug pricing regulation

作　　者：刘昕[1] 史录文[1,2] 

机构地区：[1]北京大学药学院药事管理与临床药学系,北京100083 [2]北京大学医药管理国际研究中心,北京100083

出　　处：《中国新药杂志》2008年第23期1993-1995,2002,共4页Chinese Journal of New Drugs

摘　　要：研究日本的药品价格管理模式,为我国的药品价格管理政策制定、政府部门决策提供参考。通过文献研究及比较,阐述日本药品价格管理政策,并对其进行评价,最后提出日本做法对我国药品价格管理政策的启示,并针对我国国情提出建议。日本的药品价格管理成果显著,尤其在新药定价、创新药评价、市场价格调查、仿制药定价等方面有较为科学的定价流程及依据,而且在定价方法中融入了药物经济学思想,值得我国借鉴。In this review, we described the Japanese drug pricing model to make reference to the drug price administration and government decision in our country. We studied literature and made comparison to introduce and evaluate the Japanese drug pricing model. Through comparing the drug price administration policy in China and Japan, we put forward opinions and proposals for the improvement of the relevant policy. Japanese drug price administration has made remarkable results, particularly in the new drug pricing process, novel drug evaluating, market price survey, and generic drug pricing. Especially, the new drug pricing method evolves the pharmacoeconomics thoughts. It deserves our reference.

关 键 词：日本 药品价格 管理模式 

分 类 号：R951[医药卫生—药学]